405 related articles for article (PubMed ID: 29502984)
1. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
[TBL] [Abstract][Full Text] [Related]
3. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
4. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
5. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
Simon JA; Kingsberg SA; Shumel B; Hanes V; Garcia M; Sand M
Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
8. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
[TBL] [Abstract][Full Text] [Related]
10. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.
Kamrul-Hasan ABM; Hannan MA; Alam MS; Aalpona FTZ; Nagendra L; Selim S; Dutta D
Medicine (Baltimore); 2024 Jun; 103(25):e38592. PubMed ID: 38905407
[TBL] [Abstract][Full Text] [Related]
11. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.
Clayton AH; Croft HA; Yuan J; Brown L; Kissling R
J Sex Med; 2018 Jan; 15(1):43-51. PubMed ID: 29289374
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
[TBL] [Abstract][Full Text] [Related]
13. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
Kornstein SG; Simon JA; Apfel SC; Yuan J; Barbour KA; Kissling R
J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
[TBL] [Abstract][Full Text] [Related]
14. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
Gao Z; Yang D; Yu L; Cui Y
J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
[TBL] [Abstract][Full Text] [Related]
16. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
17. Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin.
Simon JA; Clayton AH; Kim NN; Patel S
Sex Med; 2022 Feb; 10(1):100476. PubMed ID: 34999484
[TBL] [Abstract][Full Text] [Related]
18. Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.
Simon JA; Clayton AH; Goldstein I; Kingsberg SA; Shapiro M; Patel S; Kim NN
Sex Med; 2022 Dec; 10(6):100570. PubMed ID: 36400683
[TBL] [Abstract][Full Text] [Related]
19. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
Robinson K; Cutler JB; Carris NW
Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
[TBL] [Abstract][Full Text] [Related]
20. Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study.
Simon JA; Clayton AH; Parish SJ; Apfel SC; Millheiser L
J Sex Med; 2020 Jan; 17(1):83-93. PubMed ID: 31735618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
